Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Item
http://www.wikidata.org/entity/Q35961706
Gene expression profiling offers insights into the role of innate immune signaling in SScMolecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesIntegrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.Use of biologics and other novel therapies for the treatment of systemic sclerosis.Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology
P2860

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Item
http://www.wikidata.org/entity/Q35961706
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@ast
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@en
type
label
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@ast
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@en
prefLabel
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@ast
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Nilotinib (Tasigna™) in the tr ...... en-label, pilot clinical trial
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932